Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06122961 · ClinicalTrials.gov registry record
Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
A clinical trial of Heart Failure and Chronic Kidney Disease, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 18,198
- Enrollment target
- 20
- Study locations
NCT06122961 is a study of Heart Failure and Chronic Kidney Disease that has completed, run by Novo Nordisk A/S. The registered enrollment target is 18,198 participants, above the 2,003-participant average among 397 other Heart Failure trials with a reported enrollment target (809% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT06122961, a study of Heart Failure and Chronic Kidney Disease, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 18,198 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease). Participants will continue their normal care and will not get any treatment other than those the study doctor has prescribed.
Conditions Studied
Interventions
- OTHER No treatment given
Study Locations (20)
Buenos Aires
- Hospital Italiano Regional Sur - Bahía Blanca
- Clínica Coronel Suarez - Coronel Suárez
- Hospital Italiano de la Plata - La Plata
- Centro Médico CIMEL - Lanús Este
Other
- DIM Clinica Privada - Buenos Aires
- Instituto de Investigaciones Clinicas Quilmes SRL - Buenos Aires
- Instituto Médico DAMIC - Córdoba
- Hospital Luis Lagomaggiore - Mendoza
São Paulo
- i9 Pesquisas Clínicas - Campinas
- Hospital Alemão Oswaldo Cruz - São Paulo
California
- Mission Cardiovascular Research Institute - Fremont
Texas
- Texas Institute of Cardiology PA - McKinney
Buenos Aires, Argentina
- Fundacion Favaloro - CABA
Santa Fe Province
- INECO Neurociencias Oroño - Rosario
New South Wales
- Renal Research Gosford - Gosford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,198 participants |
| Start Date | 2023-11-23 |
| Est. Completion | 2025-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06122961
The ClinicalTrials.gov registry entry for NCT06122961 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 18,198 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,003-participant average among 397 other Heart Failure trials with a reported enrollment target (809% higher). The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which No treatment given is the first listed.
NCT06122961 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Buenos Aires, Other, São Paulo.
Frequently Asked Questions
What is clinical trial NCT06122961 about?
NCT06122961 is a clinical study titled "Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)". This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease). Participants will continue their normal care and will not get any treatment other than those the study doctor has prescribed.
What is the current status of trial NCT06122961?
This trial is currently completed. The enrollment target is 18,198 participants. The study started on 2023-11-23. Estimated completion is 2025-04-30.
What conditions does trial NCT06122961 study?
This clinical trial studies the following conditions: Heart Failure, Chronic Kidney Disease, Cardiovascular Risk.
What interventions are being tested in trial NCT06122961?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT06122961?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06122961 being conducted?
This trial has 20 study locations across California, Texas, Buenos Aires, Buenos Aires, Argentina, Santa Fe Province. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.